# OnCo record pharmaand (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/pharmaand/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "pharmaand" ;
  schema:name "pharma&"@en ;
  schema:alternateName "pharmaand GmbH"@en, "pharma& GmbH"@en, "pharmaand"@en ;
  schema:description "pharma& is a Vienna company that buys and markets established medicines, including the PARP inhibitor rucaparib (Rubraca), which it acquired from Clovis Oncology's bankruptcy in 2023."@en ;
  schema:url <https://onco.cc/companies/pharmaand/>, <https://www.pharmaand.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.pharmaand.com>, <https://clinicaltrials.gov/search?lead=pharmaand> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "AT" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:drugs <https://onco.cc/drugs/rucaparib/> ;
  onco:companies <https://onco.cc/companies/clovis-oncology/> .